The detection of Ki-67 is also used as a classification factor to differentiate low- and high-grade gliomas (72, 73) as well as a prognostic factor correlating with the overall survival (OS) of isocitrate dehydrogenase (IDH) WT GBM patients (74). This evidence concerns the gene IDH3A and glioma.